November 3, 2026 · American journal of respiratory and critical care medicine · DOI: 10.1093/ajrccm/aamag577

As-needed inhaled corticosteroids in asthma: an Official American Thoracic Society clinical practice guideline.

Listen to this summary

This American Thoracic Society guideline asks whether inhaled corticosteroid (ICS)-containing reliever therapy, either as ICS-formoterol or ICS plus SABA, should replace SABA-only reliever treatment in adolescents and adults with asthma across NAEPP steps 1-5. Using systematic reviews and GRADE assessments, the panel issued strong recommendations for as-needed ICS-SABA or ICS-formoterol over SABA-only therapy at steps 1-2 and for maintenance-and-reliever therapy (MART) with ICS-formoterol over scheduled ICS-LABA plus SABA at steps 3-5. They also made conditional recommendations favoring ICS+SABA reliever over SABA reliever for patients on scheduled ICS-LABA, weighing prevention of severe exacerbations against SABA-only risks and ICS and systemic corticosteroid exposure.

Sandhya Khurana, Alex R Jenkins, Helen K Reddel, Praveen Akuthota, Rodolfo M Alpizar-Rivas, Juan Carlos Cardet, Melody G Duvall, O'Neil J Green, Tina V Hartert, Elliot Israel, Nizar N Jarjour, Christopher M Kearney, Shandra L Knight, Ashley J Losier, Njira L Lugogo, Arjun Mohan, Paul M O'Byrne, Richard P Ramonell, Sunita Sharma, Neha Solanki, Charlie Strange, Glen G Stevenson, Mark A Aronica

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play